Curcumin: Multiple molecular targets mediate multiple pharmacological actions - A review

Drugs of the Future

Volumn 35, Issue 2, 2010, Pages 113-119

  Shehzad, A ^a   Lee, Y S ^a  

^a Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 6; LIPOXYGENASE; MESALAZINE; PHENYLBUTAZONE; PROTEIN BCL 2; SALAZOSULFAPYRIDINE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR;

ALCOHOL LIVER DISEASE; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRITIS; BONE CANCER; BRAIN TUMOR; BREAST CANCER; CARDIOVASCULAR DISEASE; CELL KILLING; CHRONIC DISEASE; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; DOWN REGULATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG POTENTIATION; DRUG SELECTIVITY; DRUG TARGETING; EYE DISEASE; EYE INFLAMMATION; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IRIDOCYCLITIS; LEUKEMIA; LIVER INJURY; LUNG CANCER; LYMPHOMA; MELANOMA; MULTIPLE MYELOMA; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW; SKIN INJURY; TRANSACTIVATION; ULCERATIVE COLITIS; UROGENITAL TRACT CANCER; VIRUS INHIBITION; WOUND HEALING;

EID: 84930541017     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2010.035.02.1426640     Document Type: Review

References (44)

1. Singh, S. From exotic spice to modern drug? Cell 2007, 130(5): 765-8.
2. Goel, A., Kunnumakkara, A.B., Aggarwal, B.B. Curcumin as "curecumin" from kitchen to clinic. Biochem Pharm 2008, 75(4): 787-809.
3. Chattopadhyay, I., Biswas, K., Bandyopadhyay, U., Banerjee, R.K. Turmeric and curcumin: Biological actions and medicinal applications. Current Science 2004, 87(1): 44-53.
4. Steward, W.P., Gescher, AJ. Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research. Mol Nutr Food Res 2008, 52(9): 1005-9.
5. Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B. Bioavailability of curcumin: Problems and promises. Mol Pharm 2007, 4(6): 807-18.
6. WHO Geneva. Evaluation of certain food additives. WHO Technical Report Series 891, 2000.
7. Lao, CD., Ruffin, M.T., Normolle, D. et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006, 6: 10.
8. Aggarwal, B.B., Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci 2009, 30(2): 85-94.
9. Shishodia, S., Singh, T., Chaturvedi, M.M. Modulation of transcription factors by curcumin. Adv Exp Med Biol 2007, 595: 127-48.
10. Chadalapaka, G., Jutooru, I., Chintharlapalli, S., Papineni, S., Smith, R. III, Li, X., Safe, S. Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 2008, 68(13): 5345-54.
11. Aggarwal, B.B., Bhatt, I.D., Ichikawa, H. et al. Curcumin - Biological and medicinal properties. In: Turmeric: The Genus Curcuma. Ravindran, P.N., K.N. Babu, Sivaraman. K. (Eds.). CRC Press: Florida, 2006, 297-368.
12. Park, M.J., Kim, E.H., Park, I.C. et al. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. Int J Oncol 2002, 21(2): 379-83.
13. Anto, R.J., Mukhopadhyay, A., Denning, K., Aggarwal, B.B. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 2002, 23(1): 143-50.
14. Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett 2008, 267(1): 133-64.
15. Aggarwal, B.B., Kumar, A., Bharti, A.C. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003, 23(1A): 363-98.
16. Aggarwal, S., Takada, Y., Singh, S., Myers, J.N., Aggarwal, B.B. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 2004, 111(5): 679-92.
17. Lee, K.W., Kim, J.H., Lee, H.J., Surh, Y.J. Curcumin inhibits phorbolester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 2005, 7(11-12): 1612-20.
18. Hanai, H., Iida, T., Takeuchi, K. et al. Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006; 4(12): 1502-6.
19. Mishra, S., Pelanalvenu, K. The effect of curcumin (turmeric) on alzheimers disease. Ann Indian Acad Neurol 2008, 11(1): 13-9.
20. Giri, R.K., Rajagopal, V., Kalra, V.K. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 2004, 91(5): 1199-210.
21. Kim, C.Y, Kim, K.H., Lee, S.H. et al. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 2005, 174(12): 8116-24.
22. Rathore, P., Dohare, P., Varma, S., Ray, A., Sharma, U., Jagannathan, N.R., Ray, M. Curcuma oil: Reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain. Neurochem Res 2008, 33(9): 1672-82.
23. Jiang, J., Wang, W., Sun, Y.J., Hu, M., Li, F., Zhu, D.Y. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur J Pharmacol 2007, 561(1-3): 54-62.
24. Naidu, K.A., Thippeswamy, N.B. Inhibition of human low density lipoprotein oxidation by active principles from spices. Mol Cell Biochem 2002, 229(1-2): 19-23.
25. Egan, M.E., Pearson, M., Weiner S.A. et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004, 304(5670): 600-2.
26. Li, H.L., Liu, C., de Couto, G. et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008, 118(3): 879-93.
27. Arun, N., Nalini, N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rots. Plant Foods Hum Nutr 2002, 57(1): 41-52.
28. Weisberg, S.P., Leibel, R., Tortoriello, D.V. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008, 149(7): 3549-58.
29. Babu, P.S., Srinivasan, K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 1997, 166(1-2): 169-75.
30. Premila, M.S. Antirheumatic agents. In: Ayurvedic Herbs: A Clinical Guide to the Healing Plants of Traditional Indian Medicine. The Haworth Press: New York, 2006, 163-92.
31. Liacini, A., Sylvester, J., Li, W.Q., Zafarullah, M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002, 21(3): 251-62.
32. Nanji, A.A., Jokelainen, K., Tipoe, C.L., Rahemtulla, A., Thomas, P., Dannenberg, A.J. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am J Physiol Gastrointest Liver Physiol 2003, 284(2): G321-7.
33. Gukovsky, I., Reyes, C.N., Vaquera, E.C., Gukovskaya, A.S., Pandol, S.J. Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 2003, 284(1): G85-95.
34. Xu, J., Fu, Y., Chen, A. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 2003, 285(1): G20-30.
35. Fahey, A.J., Adrian, Robins, R., Constantinescu, C.S. Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells. J Cell Mol Med 2007, 11(5): 1129-37.
36. Mani, H., Sidhu, G.S., Kumari, R., Gaddipati, J.P., Seth, P., Maheshwari, R.K. Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing. Biofactors 2002, 16(1-2): 29-43.
37. Panchatcharam, M., Miriyala, S., Gayathri, V.S., Suguna, L. Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species. Mol Cell Biochem 2006, 290(1-2): 87-96.
38. Phan, T.T., See, P., Lee, S.T., Chan, S.Y. Protective effects of curcumin against oxidative damage on skin cells in vitro: Its implication for wound healing. J Trauma 2001, 51(5): 927-31.
39. Sui, Z., Salto, R., Li, J., Craik, C., Ortiz de Montellano, P.R. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1993, 1(6): 415-22.
40. Mazumder, A., Neamati, N., Sunder, S., Schulz, J., Pertz, H., Eich, E., Pommier, Y. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem 1997, 40(19): 3057-63.
41. Barthelemy, S., Vergnes, L., Moynier, M., Guyot, D., Labidalle, S., Bahraoui, E. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol 1998, 149(1): 43-52.
42. Lal, B., Kapoor, A.K., Asthana, O.P., Agrawal, P.K., Prasad, R., Kumar, P., Srimal, R.C. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 1999, 13 (4): 318-22.
43. Chen, M., Hu, D.N., Pan, Z., Lu, C.W., Xue, C.Y., Aass, I. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways. Exp Eye Res 2009, In press.
44. Syng-Ai, C., Kumari, A.L., Khar, A. Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2. Mol Cancer Ther 2004, 3(9): 1101-8.